Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution

BACKGROUND: Doxorubicin is the key drug for treatment of advanced soft tissue sarcoma (STS). The appropriate dosage of doxorubicin, regarding monotherapy or the role of combination therapy, is unclear. METHODS: We retrospectively reviewed patients with advanced or metastatic STS of nonextremities wh...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Sarcoma
Autori principali: Marshall, Shoko, Nakano, Kenji, Sugiura, Yoshiya, Taira, Shinichiro, Ono, Makiko, Tomomatsu, Junichi, Takahashi, Shunji
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2018
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5932429/
https://ncbi.nlm.nih.gov/pubmed/29849480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8926598
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi